L17E
L17E selectively directs its actions towards critical immune cells, thereby mitigating inflammation and impeding the progression of debilitating ailments. Through an array of exceptional preclinical investigations, L17E has exhibited remarkable outcomes and presents an unprecedented mechanism of action, instilling steadfast hope towards a paradigm shift in the realm of autoimmune disease management.
Online Inquiry
| CAT# | GR2206 |
| CAS | 2305578-13-4 |
| M.F/Formula | C134H219N37O32S |
| M.W/Mr. | 2860.41 |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
